Syndecan 1 is a therapeutic target for KRAS-driven pancreatic cancer

被引：0
|
作者：
Takeda, Mitsunobu
Yang, Zecheng
Theardy, Madeline S.
Sorokin, Alexey
Coker, Oluwadara
Chen, Shuaitong
Vien, Long T.
Bover, Laura
Ying, Haoqiang
Kopetz, Scott
Yao, Wantong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-IA-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA-08
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
    Dey, Prasenjit
    Li, Jun
    Zhang, Jianhua
    Chaurasiya, Surendra
    Strom, Anders
    Wang, Huamin
    Liao, Wen-Ting
    Cavallaro, Frederick
    Denz, Parker
    Bernard, Vincent
    Yen, Er-Yen
    Genovese, Giannicola
    Gulhati, Pat
    Liu, Jielin
    Chakravarti, Deepavali
    Deng, Pingna
    Zhang, Tingxin
    Carbone, Federica
    Chang, Qing
    Ying, Haoqiang
    Shang, Xiaoying
    Spring, Denise J.
    Ghosh, Bidyut
    Putluri, Nagireddy
    Maitra, Anirban
    Wang, Y. Alan
    DePinho, Ronald A.
    CANCER DISCOVERY, 2020, 10 (04) : 608 - 625
  • [42] Matrine suppresses KRAS-driven pancreatic cancer growth by inhibiting autophagy-mediated energy metabolism
    Cho, Young-ra
    Lee, Ji Hyeon
    Kim, Ji Hye
    Lee, So-Yeon
    Yoo, Suna
    Jung, Min-kyo
    Kim, Su Jung
    Yoo, Hyun Ju
    Pack, Chang-Gi
    Rho, Jin Kyung
    Son, Jaekyoung
    MOLECULAR ONCOLOGY, 2018, 12 (07) : 1203 - 1215
  • [43] Targeting copper metabolism to defeat KRAS-driven colorectal cancer
    Aubert, Leo
    Nandagopal, Neethi
    Roux, Philippe P.
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (06)
  • [44] Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer
    Wang, Dong
    Cong, Jingjing
    Fu, Binqing
    Zheng, Xiaohu
    Sun, Rui
    Tian, Zhigang
    Wei, Haiming
    CANCER LETTERS, 2020, 492 : 31 - 43
  • [45] A treatment strategy for KRAS-driven tumors
    Trang T. Mai
    Piro Lito
    Nature Medicine, 2018, 24 : 902 - 904
  • [46] Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer
    Mariluz Soula
    Gokhan Unlu
    Rachel Welch
    Aleksey Chudnovskiy
    Beste Uygur
    Vyom Shah
    Hanan Alwaseem
    Paul Bunk
    Vishvak Subramanyam
    Hsi-Wen Yeh
    Artem Khan
    Søren Heissel
    Hani Goodarzi
    Gabriel D. Victora
    Semir Beyaz
    Kıvanç Birsoy
    Nature, 2024, 633 (8029) : 451 - 458
  • [47] Extracellular RNA signatures of mutant KRAS-driven lung cancer
    Maroli, Sree Lakshmi Velandi
    Reggiardo, Roman E.
    Khojah, Reem
    Kim, Daniel H.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [48] Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells
    Bernfeld, Elyssa
    Foster, David A.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (06): : 357 - 368
  • [49] From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers
    Saliani, Mahsa
    Jalal, Razieh
    Ahmadian, Mohammad Reza
    CANCER BIOLOGY & MEDICINE, 2019, 16 (03) : 435 - 461
  • [50] Nrdc inhibits Kras-driven pancreatic tumorigenesis through suppressing spontaneous pancreatitis
    Ikuta, Kozo
    Fukuda, Akihisa
    Tsuda, Tomoyuki
    Maruno, Takahisa
    Kanda, Keitaro
    Nishi, Eiichirou
    Seno, Hiroshi
    CANCER SCIENCE, 2018, 109 : 514 - 514
12345